XML 31 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Segment and Geographic Data
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Segment and Geographic Data SEGMENT AND GEOGRAPHIC DATA
We segregate our operations into three reportable business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine.
The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.
Segment Results202020192018
Orthopaedics$4,959 $5,252 $4,991 
MedSurg$6,400 6,492 6,045 
Neurotechnology & Spine2,992 3,140 2,565 
Net sales$14,351 $14,884 $13,601 
Orthopaedics$344 $348 $350 
MedSurg362 379 285 
Neurotechnology & Spine248 218 176 
Segment depreciation and amortization $954 $945 $811 
Corporate and Other122 99 155 
Total depreciation and amortization$1,076 $1,044 $966 
Orthopaedics$1,518 $1,907 $1,804 
MedSurg1,837 1,642 1,444 
Neurotechnology & Spine647 839 700 
Segment operating income$4,002 $4,388 $3,948 
Items not allocated to segments:
Corporate and Other$(503)$(480)$(431)
Acquisition and integration-related charges(242)(275)(123)
Amortization of intangible assets(472)(464)(417)
Restructuring-related and other charges(458)(226)(220)
Medical device regulations(81)(62)(12)
Recall-related matters(17)(192)(23)
Regulatory and legal matters(6)24 (185)
Consolidated operating income$2,223 $2,713 $2,537 
Segment Assets and Capital Spending
Assets:202020192018
Orthopaedics$14,910 $9,085 $8,873 
MedSurg17,901 12,066 10,417 
Neurotechnology & Spine529 7,646 7,260 
Total segment assets$33,340 $28,797 $26,550 
Corporate and Other990 1,370 679 
Total assets$34,330 $30,167 $27,229 
Capital spending:
Orthopaedics$140 $125 $134 
MedSurg174 265 217 
Neurotechnology & Spine28 29 31 
Total segment capital spending$342 $419 $382 
Corporate and Other145 230 190 
Total capital spending$487 $649 $572 
We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally cash and cash equivalents, marketable securities and property, plant and equipment.
The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated.
Geographic Information
Net SalesNet Property, Plant and Equipment
20202019201820202019
United States$10,455 $10,957 $9,848 $1,645 $1,561 
Europe, Middle East, Africa1,818 1,888 1,793 938 838 
Asia Pacific1,630 1,617 1,532 91 95 
Other countries448 422 428 78 73 
Total$14,351 $14,884 $13,601 $2,752 $2,567